Finally, the discovery of sex-biased chromosomal alterations, including LoX, suggests that CIN pathways in glioma may be modulated by sex chromosome dosage, XCI escape, and sex-specific selective pressures. This evidence concerns the gene LOX and central nervous system cancer.